UA102370C2 - Пептид, фармацевтическая композиция и лекарственное средство, которое его содержит, способ лечения и/или предупреждения диабета и сопутствующих ожирению заболеваний, способ снижения аппетита, снижение поглощения пищи и снижение массы тела - Google Patents

Пептид, фармацевтическая композиция и лекарственное средство, которое его содержит, способ лечения и/или предупреждения диабета и сопутствующих ожирению заболеваний, способ снижения аппетита, снижение поглощения пищи и снижение массы тела

Info

Publication number
UA102370C2
UA102370C2 UAA200907137A UAA200907137A UA102370C2 UA 102370 C2 UA102370 C2 UA 102370C2 UA A200907137 A UAA200907137 A UA A200907137A UA A200907137 A UAA200907137 A UA A200907137A UA 102370 C2 UA102370 C2 UA 102370C2
Authority
UA
Ukraine
Prior art keywords
glu15
tyr21 phe22
lys20 tyr21
val19 lys20
glu24
Prior art date
Application number
UAA200907137A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Стівен Роберт Блум
Original Assignee
Імпіеріел Інноувейшнс Лімітид
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Імпіеріел Інноувейшнс Лімітид filed Critical Імпіеріел Інноувейшнс Лімітид
Priority claimed from PCT/GB2007/004779 external-priority patent/WO2008071972A1/en
Publication of UA102370C2 publication Critical patent/UA102370C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
UAA200907137A 2006-12-13 2007-12-13 Пептид, фармацевтическая композиция и лекарственное средство, которое его содержит, способ лечения и/или предупреждения диабета и сопутствующих ожирению заболеваний, способ снижения аппетита, снижение поглощения пищи и снижение массы тела UA102370C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0624868.6A GB0624868D0 (en) 2006-12-13 2006-12-13 Novel compounds and their effects on feeding behaviour
PCT/GB2007/004779 WO2008071972A1 (en) 2006-12-13 2007-12-13 Novel compounds and their effects on feeding behaviour

Publications (1)

Publication Number Publication Date
UA102370C2 true UA102370C2 (ru) 2013-07-10

Family

ID=37712059

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907137A UA102370C2 (ru) 2006-12-13 2007-12-13 Пептид, фармацевтическая композиция и лекарственное средство, которое его содержит, способ лечения и/или предупреждения диабета и сопутствующих ожирению заболеваний, способ снижения аппетита, снижение поглощения пищи и снижение массы тела

Country Status (4)

Country Link
CN (1) CN101578107B (zh)
GB (1) GB0624868D0 (zh)
UA (1) UA102370C2 (zh)
ZA (1) ZA200903770B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3878859T3 (da) 2011-06-10 2024-01-02 Hanmi Science Co Ltd Hidtil ukendte oxyntomodulinderivater og farmaceutisk præparat til behandling af fedme omfattende disse
HUE042585T2 (hu) 2011-06-17 2019-07-29 Hanmi Science Co Ltd Oxintomodulint és immunglobulin-fragmentumot tartalmazó konjugátum és alkalmazása
KR101968344B1 (ko) 2012-07-25 2019-04-12 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
EP2916819B1 (en) 2012-11-06 2019-07-10 Hanmi Pharm. Co., Ltd. Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
KR101993393B1 (ko) 2012-11-06 2019-10-01 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
TWI772252B (zh) 2014-09-16 2022-08-01 南韓商韓美藥品股份有限公司 長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
KR102418477B1 (ko) 2014-12-30 2022-07-08 한미약품 주식회사 글루카곤 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
CN1189480C (zh) * 2002-03-25 2005-02-16 中国科学院昆明动物研究所 饱食因子及其制备方法
WO2005035761A1 (en) * 2003-10-16 2005-04-21 Compugen Ltd. Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin

Also Published As

Publication number Publication date
CN101578107B (zh) 2014-03-19
GB0624868D0 (en) 2007-01-24
ZA200903770B (en) 2010-05-26
CN101578107A (zh) 2009-11-11

Similar Documents

Publication Publication Date Title
MX2009006348A (es) Nuevos compuestos y sus efectos sobre el conductismo de la alimentacion.
UA102370C2 (ru) Пептид, фармацевтическая композиция и лекарственное средство, которое его содержит, способ лечения и/или предупреждения диабета и сопутствующих ожирению заболеваний, способ снижения аппетита, снижение поглощения пищи и снижение массы тела
JP2009529553A5 (zh)
JP2005534647A5 (zh)
CA2309356A1 (en) Novel exendin agonist compounds
JP2008514624A5 (zh)
de Rougemont et al. Preconditioning, organ preservation, and postconditioning to prevent ischemia‐reperfusion injury to the liver
de Rougemont et al. Biological modulation of liver ischemia–reperfusion injury
W. POTTS et al. The effects of hypophysectomy and bovine prolactin on salt fluxes in fresh-water-adapted Fundulus heteroclitus
Huijink et al. Metformin preconditioning and postconditioning to reduce ischemia reperfusion injury in an isolated ex vivo rat and porcine kidney normothermic machine perfusion model
Fröhlich et al. Induced hypothermia reduces the hepatic inflammatory response in a swine multiple trauma model
FR2839722A1 (fr) Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
Cisco
Cisco
Cisco
Cisco
Miller Overview of the efficacy and safety of SGLT-2 inhibitors in type 2 diabetes mellitus
Egers et al. Sodium-glucose co-transporter 2 inhibitors in 2022: mechanisms of cardiorenal benefit
Meng et al. Auxiliary Therapeutic Effects of Emodin on Diabetic Nephropathy
Bezeljak et al. Pathophysiological changes and systemic inflammation in brain dead organ donors: effect on graft quality
Daniels Andrew Luck Announces His Retirement Two Weeks Before the Start of the 2019 Season
Saini Periodontitis: A risk factor for pre-eclampsia
Alsabbagh Peginterferon-α-2a/ribavirin
Chan et al. Weight loss in the renal transplant candidate: A clinical review of the efficacy of conservative and surgical treatments.: Abstract# B911
Pechman Metoprolol overdose